CENTER FOR MEDICAL PROGRESS

INVITES YOU TO AN EVENING SYMPOSIUM

MONDAY, NOVEMBER 13, 2006
6:00 PM–7:30 PM

Harvard Club
35 West 44th Street
New York City

SPEAKER:
Dr. Scott Gottlieb
Deputy Commissioner for Medical and Scientific Affairs,
U.S. Food and Drug Administration

ON
FROM LAB BENCH TO BEDSIDE:
HOW THE FDA IS USING NEW TECHNOLOGIES TO ENSURE
THE SAFETY AND EFFECTIVENESS OF AMERICA’S MEDICINES

Since its inception in 1906, the FDA's mandate has grown to encompass the safety of a wide array of consumer goods, ranging from cosmetics to vaccines and even cellular phones. Today, the agency regulates products that account for 25 percent of U.S. consumer spending, or about $1 trillion each year.

But the FDA's best known responsibility is ensuring that Americans have timely access to safe and effective medicines for treating illnesses ranging from cancer to Alzheimer's disease. As a result, the agency must make complex decisions involving the prospective benefits and risks of new medicines before they are approved for public sale— decisions that are, by their very nature, open to criticism and debate.

Please join us as Dr. Scott Gottlieb discusses the agency’s efforts to leverage new technologies and scientific advances to ensure that its regulatory decisions are based on the best possible information and evidence.

Name:*

Affiliation:*

Phone:*

Email:*

YOU ARE CORDIALLY INVITED TO ATTEND. THERE IS NO CHARGE,
But if you accept and find you are unable to attend, please be sure to let us know.

If you have any problems submitting your registration online, please contact Taisha Camacho, Event Coordinator, 212-599-7000 or tcamacho@manhattan-institute.org.